ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Anaesthesia for Craniotomy: Physiological Principles and Clinical Management

Topic notes · Applied Anaesthesia · Neuroanaesthesia

Anaesthesia for craniotomy demands a thorough comprehension of cerebral blood flow physiology and autoregulation to guarantee adequate perfusion and prevent elevated intracranial pressure. The anaesthetist strives to provide optimal surgical conditions through brain relaxation, prevention of ischemia, and meticulous haemodynamic stability.

Neurophysiology and Cerebral Perfusion Pressure

Normal cerebral blood flow (CBF) is approximately 50 mL/100 g/min, while normal cerebral metabolic rate of oxygen (CMRO2) is 3.0 to 3.5 mL/100 g/min, accounting for roughly 20% of total body oxygen consumption. Cerebral autoregulation maintains constant CBF over a mean arterial pressure (MAP) range of 50 to 150 mm Hg. Cerebral perfusion pressure is determined by the formula CPP = MAP - ICP. Cerebral vasculature responds exquisitely to carbon dioxide: CBF changes by 1 to 2 mL/100 g/min per 1 mm Hg change in PaCO2, and an increase of 1 kPa in PaCO2 elevates CBF by 30% until maximal dilation is reached at 10 kPa or greater.

Anaesthetic Drug Selection and Volatile Agents

Intravenous hypnotics such as Propofol, Thiopental, and Etomidate decrease CMRO2, CBF, and ICP while preserving autoregulation and CO2 reactivity. Conversely, Ketamine increases all three parameters and is contraindicated in neuroanaesthesia. Volatile anesthetics uncouple cerebral metabolism and flow; however, Sevoflurane is preferred because it best preserves autoregulation and causes minimal vasodilation, with concentrations under 1 MAC leaving ICP largely unaffected. Enflurane is strictly avoided due to EEG seizure activity, and Nitrous oxide is withheld due to increases in CBF, CMRO2, ICP, and the risk of worsening tension pneumocephalus.

Brain Relaxation and ICP Management

Elevated ICP is defined as a sustained pressure above 15 mm Hg, whereas brain relaxation reflects tactile firmness with the cranium open where ICP equals 0 mm Hg. Peritumoral vasogenic edema is managed with Dexamethasone 4 mg 6-hourly to decrease blood-brain barrier permeability, although it has no effect on cytotoxic edema. Head-up positioning of 15 to 30 degrees promotes venous and CSF drainage provided MAP is maintained. Mannitol (0.25 to 1 g/kg IV) demonstrates an onset of 5 to 10 minutes and peaks at 20 to 30 minutes; rapid administration should be avoided to prevent systemic vasodilation, hypotension, and transient ICP spikes. Furosemide offers synergistic reductions.

Monitoring, Fluid Balance, and Emergence Cautions

Invasive arterial pressure transducers must be zeroed at the external auditory meatus (circle of Willis level) to accurately guide CPP. Direct vasodilators such as Nicardipine or Nitroglycerin must be strictly avoided before dural opening to prevent increases in cerebral blood volume and ICP; Phenylephrine is preferred for hypotension. Dextrose-containing solutions must be avoided to prevent anaerobic exacerbation of ischemia, and hypotonic fluids must be avoided to prevent lowering plasma osmolality and aggravating edema. During emergence, coughing and bucking on the tube must be prevented to avoid intracranial hemorrhage, and volatile agent wash-out must be confirmed below 0.2 MAC to avert delayed awakening.

Key points
  • Normal CBF is 50 mL/100 g/min, maintained by autoregulation within a MAP range of 50 to 150 mm Hg.
  • Sevoflurane is the preferred volatile agent preserving autoregulation, whereas Enflurane is contraindicated due to epileptogenic risk and Ketamine due to ICP rise.
  • Mannitol is administered at 0.25 to 1 g/kg peaking at 20 to 30 minutes; rapid infusion must be avoided to prevent hypotension and transient volume expansion.
  • Arterial transducers must be zeroed at the external auditory meatus to calculate CPP, while dextrose and hypotonic intravenous solutions must be strictly avoided.

Sources

  • Smith and Aitkenhead's Textbook of Anaesthesia, 8th Edition, p. 780
  • Miller's Basics of Anesthesia, 8th Edition, p. 533
  • Miller's Basics of Anesthesia, 8th Edition, p. 534
  • Miller's Basics of Anesthesia, 8th Edition, p. 536
  • Miller's Basics of Anesthesia, 8th Edition, p. 540
  • Miller's Anesthesia, 9th Edition, p. 2487
  • Miller's Anesthesia, 9th Edition, p. 2514
  • Oxford Handbook of Anaesthesia, 4th Edition, p. 450
  • Morgan & Mikhail's Clinical Anesthesiology, 7th Edition, p. 565
  • Morgan & Mikhail's Clinical Anesthesiology, 7th Edition, p. 566
  • Morgan & Mikhail's Clinical Anesthesiology, 7th Edition, p. 567

Test yourself: 20 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.